Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:10993333rdf:typepubmed:Citationlld:pubmed
pubmed-article:10993333lifeskim:mentionsumls-concept:C0013018lld:lifeskim
pubmed-article:10993333lifeskim:mentionsumls-concept:C0567416lld:lifeskim
pubmed-article:10993333lifeskim:mentionsumls-concept:C0023690lld:lifeskim
pubmed-article:10993333lifeskim:mentionsumls-concept:C0035668lld:lifeskim
pubmed-article:10993333lifeskim:mentionsumls-concept:C0039959lld:lifeskim
pubmed-article:10993333lifeskim:mentionsumls-concept:C0220781lld:lifeskim
pubmed-article:10993333lifeskim:mentionsumls-concept:C0041525lld:lifeskim
pubmed-article:10993333lifeskim:mentionsumls-concept:C0486805lld:lifeskim
pubmed-article:10993333lifeskim:mentionsumls-concept:C1883254lld:lifeskim
pubmed-article:10993333lifeskim:mentionsumls-concept:C0185125lld:lifeskim
pubmed-article:10993333lifeskim:mentionsumls-concept:C0049715lld:lifeskim
pubmed-article:10993333pubmed:issue17lld:pubmed
pubmed-article:10993333pubmed:dateCreated2000-10-10lld:pubmed
pubmed-article:10993333pubmed:abstractText4-Thiouridine, 6-thioguanosine, and 6-thioinosine 3',5'-bisphosphates (9, 20, and 28) were synthesized in good yields by considerably improved methods. In the former two compounds, uridine and 2-N-phenylacetylguanosine were converted via transient O-trimethylsilylation to the corresponding 4- and 6-O-benzenesulfonyl intermediates (2 and 13), which, in turn, were allowed to react with 2-cyanoethanethiol in the presence of N-methylpyrrolidine to give 4-thiouridine (3) and 2-N-phenylacetyl-6-thioguanosine derivatives (14), respectively. In situ dimethoxytritylation of these thionucleoside derivatives gave the 5'-masked products 4 and 15 in high overall yields from 1 and 11. 6-S-(2-Cyanoethyl)-5'-O-(4,4'-dimethoxytrityl)-6-thioinosine (23) was synthesized via substitution of the 5'-O-tritylated 6-chloropurine riboside derivative 22 with 2-cyanoethanethiol. These S-(2-cyanoethyl)thionucleosides were converted to the 2'-O-(tert-butyldimethylsilyl)ribonucleoside 3'-phosphoramidite derivatives 7, 18, and 26 or 3',5'-bisphosphate derivatives 8, 19, and 27. Treatment of 8, 19, and 27 with DBU gave thionucleoside 3',5'-bisphosphate derivatives 9, 20, and 28, which were found to be substrates of T4 RNA ligase. These thionucleoside 3',5'-bisphosphates were examined as donors for ligation with m3(2,2,7) G5'pppAmUmA, i.e., the 5'-terminal tetranucleotide fragment of U1 snRNA, The 4-thiouridine 3',5'-bisphosphate derivative 9 was found to serve as the most active substrate of T4 RNA ligase with a reaction efficiency of 96%.lld:pubmed
pubmed-article:10993333pubmed:languageenglld:pubmed
pubmed-article:10993333pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10993333pubmed:citationSubsetIMlld:pubmed
pubmed-article:10993333pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10993333pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10993333pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10993333pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10993333pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10993333pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10993333pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:10993333pubmed:statusMEDLINElld:pubmed
pubmed-article:10993333pubmed:monthAuglld:pubmed
pubmed-article:10993333pubmed:issn0022-3263lld:pubmed
pubmed-article:10993333pubmed:authorpubmed-author:WadaTTlld:pubmed
pubmed-article:10993333pubmed:authorpubmed-author:SekineMMlld:pubmed
pubmed-article:10993333pubmed:authorpubmed-author:KadokuraMMlld:pubmed
pubmed-article:10993333pubmed:authorpubmed-author:SeilFFlld:pubmed
pubmed-article:10993333pubmed:issnTypePrintlld:pubmed
pubmed-article:10993333pubmed:day25lld:pubmed
pubmed-article:10993333pubmed:volume65lld:pubmed
pubmed-article:10993333pubmed:ownerNLMlld:pubmed
pubmed-article:10993333pubmed:authorsCompleteYlld:pubmed
pubmed-article:10993333pubmed:pagination5104-13lld:pubmed
pubmed-article:10993333pubmed:dateRevised2006-11-15lld:pubmed
pubmed-article:10993333pubmed:meshHeadingpubmed-meshheading:10993333...lld:pubmed
pubmed-article:10993333pubmed:meshHeadingpubmed-meshheading:10993333...lld:pubmed
pubmed-article:10993333pubmed:meshHeadingpubmed-meshheading:10993333...lld:pubmed
pubmed-article:10993333pubmed:meshHeadingpubmed-meshheading:10993333...lld:pubmed
pubmed-article:10993333pubmed:meshHeadingpubmed-meshheading:10993333...lld:pubmed
pubmed-article:10993333pubmed:meshHeadingpubmed-meshheading:10993333...lld:pubmed
pubmed-article:10993333pubmed:meshHeadingpubmed-meshheading:10993333...lld:pubmed
pubmed-article:10993333pubmed:meshHeadingpubmed-meshheading:10993333...lld:pubmed
pubmed-article:10993333pubmed:year2000lld:pubmed
pubmed-article:10993333pubmed:articleTitleSynthesis of 4-thiouridine, 6-thioinosine, and 6-thioguanosine 3',5'-O-bisphosphates as donor molecules for RNA ligation and their application to the synthesis of photoactivatable TMG-capped U1 snRNA fragments.lld:pubmed
pubmed-article:10993333pubmed:affiliationDepartment of Life Science, Tokyo Institute of Technology, Yokohama, Japan.lld:pubmed
pubmed-article:10993333pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:10993333pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:10993333lld:pubmed